Conclusion Metformin has been proven efficacy in the treatment of type 2 diabetes mellitus
Patients taking medications that affect heart rate, particularly beta-blockers, calcium channel blockers, or antiarrhythmic drugs, should be identified, as these may modify the heart rate response to GLP-1 therapy
Whether pigmentation, appetite modulation, or sexual arousal
Two-week stalls happen routinely (often related to menstrual cycles, sodium, sleep, or simple measurement noise)
The nasal route achieves systemic bioavailability that researchers have found practical for consistent melanocortin delivery
TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial